Flu illness accounts for up to 10% of all pediatric hospitalizations during the winter season in the United States.

The findings reported in the journal Immunity support the development of a monoclonal antibody for prevention and treatment of influenza B — and will help guide efforts to develop a universal influenza vaccine.

A new study led by Vanderbilt University Medical Center researchers has identified key immune cell populations that predict how well pediatric hematopoietic stem cell transplant (HCT) recipients will respond to the influenza vaccine.

The avian (bird) influenza vaccine creates a more robust immune response when paired with a potent ingredient known as an adjuvant, according to Vanderbilt research published in The Journal of Infectious Diseases.

The traditional definition of health care-associated influenza leads to gross undercounting, a Vanderbilt study suggests.

Vanderbilt research finds antiviral medications are underused in young children diagnosed with influenza despite national guidelines supporting their use